Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eiji Harada
Observed name:
E. Harada
Institution:
Eli Lilly (Japan)
Observed institutions:
Fujita Health University,
Eli Lilly (Japan)
OpenAlex ID:
A5048936916
The incremental burden of pain in patients with depression: results of a Japanese survey
2015
·
Jeffrey Vietri
, Tempei Otsubo
, et al.
·
BMC Psychiatry
·
26
PDF
Perceptions and impact of bipolar disorder in Japan: results of an Internet survey
2016
·
Koichiro Watanabe
, Eiji Harada
, et al.
·
Neuropsychiatric Disease and Treatment
·
21
PDF
Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
2016
·
Levent Alev
, Yoichi Satoi
, et al.
·
Neuropsychiatric Disease and Treatment
·
18
PDF
Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey
2015
·
Jeffrey Vietri
, William Montgomery
, et al.
·
Neuropsychiatric Disease and Treatment
·
18
PDF
Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials
2015
·
Eiji Harada
, Hirofumi Tokuoka
, et al.
·
Pain
·
16
Changes in energy during treatment of depression: an analysis of duloxetine in double‐blind placebo‐controlled trials
2015
·
E. Harada
, M. Kato
, et al.
·
International Journal of Clinical Practice
·
9
PDF
Does Early Improvement in Anxiety Symptoms in Patients with Major Depressive Disorder Affect Remission Rates? A Post-Hoc Analysis of Pooled Duloxetine Clinic Trials
2014
·
Murat Altin
, Eiji Harada
, et al.
·
Open Journal of Depression
·
9
PDF
Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study
2017
·
Eiji Harada
, Yoichi Satoi
, et al.
·
Neuropsychiatric Disease and Treatment
·
8
PDF
Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
2015
·
Eiji Harada
, Alexander Schacht
, et al.
·
Neuropsychiatric Disease and Treatment
·
6
PDF
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
2016
·
Yoichi Satoi
, Eiji Harada
, et al.
·
Neuropsychiatric Disease and Treatment
·
2
PDF
Show more works
View as search
Works count:
10
Citation count:
133
H-index:
8
I10-index:
5
Year
Topic
Type